OXFORD NANOPORE TECHNOLOGIES PLC

Regulatory News Service • Nov 27, 2025

National Storage Mechanism | Additional information

RNS Number : 1786J

Oxford Nanopore Technologies plc

27 November 2025

Oxford Nanopore Technologies plc

("Oxford Nanopore" or the "Company")

Oxford Nanopore to participate in upcoming investor conferences

27 November 2025

Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new generation of molecular sensing technology based on nanopores, will be participating in the following investor conferences in December.

·      Citi 2025 Global Healthcare Conference, Miami

Format: Analyst led fireside chat and one-on-one and group investor meetings

Date: Tuesday, 2 December

Fireside chat time: 9:45am EST (2:45pm GMT)

Webcast: click here to register

·      37th Annual Piper Sandler Healthcare Conference, New York

Format: Analyst led fireside chat and one-on-one and group investor meetings

Date: Wednesday, 3 December

Fireside chat time: 12:30pm EST (5:30pm GMT)

Webcast: click here to register

·      Berenberg European Conference, Windsor

Format: Analyst led fireside chat and one-on-one and group investor meetings

Date: Thursday, 4 December

Fireside chat time: 3:30pm GMT

Live webcasts of the Citi and Piper Sandler fireside chats can be accessed at the Company's investor relations page at: https://nanoporetech.com/about/investors/reports. Webcast replays will be available for at least 30 days following the events via the same link.

-ENDS-

For further information, please contact:

Oxford Nanopore Technologies plc

Investors:         [email protected]

Media:              [email protected]

Teneo (communications adviser to the Company)

Tom Murray, Lisa Jarrett-Kerr

+44 (0) 20 7353 4200

[email protected]

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.  Oxford Nanopore's technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare, food and agriculture.

For more information please visit: www.nanoporetech.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAEAEFKALKSFAA